/PRNewswire/ Long Grove Pharmaceuticals announced the strategic in-licensing of Norepinephrine in 0.9% Sodium Chloride premix formulation from Nevakar.
The advent of various cutting-edge technologies, including software, the internet, and Wi-Fi, has made it possible for patients to connect with service.
/PRNewswire/ 3H Medi Solution Inc., a leading Japanese clinical trial company, today announced its selection of THREAD to expand decentralized research.